Skip to main content
SpringerLink
Log in

p27kip 1 and other cell-cycle protein expression in normal and neoplastic endocrine tissues

  • Review
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Endocrine tumors are often diagnostic challenges. Recent studies have suggested that proteins that regulate cell cycle may have diagnostic and prognostic utility in endocrine tumors. p27kip 1 (p27) is a cyclin-dependent kinase inhibitor that regulates the transition from the G1 to the S phase of the cell cycle. p27 and other cell-cycle proteins are becoming increasingly important in assessing the biologic behavior of endocrine neoplasms, classifying hyperplastic and neoplastic endocrine tissues, and in the progression of endocrine tumors. p27 appears to separate normal from neoplastic endocrine tissues and, in some cases, benign from malignant endocrine tumors. However, there is overlap in p27 expression among individual cases of benign and malignant tumors, and p27 has only limited prognostic utility in endocrine tumors compared to some epithelial tumors such as breast and prostate neoplasms. Thus, more effective molecular and cellular markers that can be used for diagnostic and prognostic purposes in endocrine pathology are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer 31:600–605, 1973.

    Article  PubMed  CAS  Google Scholar 

  2. Abbona GC, Papotti M, Gasparri G, Bussolati G. Proliferative activity in parathyroid tumors as detected by Ki67 immunostaining. Hum Pathol 26:135–138, 1995.

    Article  PubMed  CAS  Google Scholar 

  3. Katoh R, Bray CE, Suzuki K, Komiyama A, Hemmi A, Kawoi A, Oyama T, Sugai T, Sasau S. Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum Pathol 26:139–146, 1995.

    Article  PubMed  CAS  Google Scholar 

  4. Kitz K, Knosp E, Koos WT, Korn A. Proliferation of pituitary adenomas: measurement by MAb Ki-67. Acta Neurochiurg Suppl (Wien) 53:60–64, 1991.

    CAS  Google Scholar 

  5. Goldblum JR, Shannon R, Keldjian EP, Thiny M, Davenport R, Thompson N, Lloyd RV. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Modern Pathol 6:663–668, 1993.

    CAS  Google Scholar 

  6. Pelosi G, Zamboni G, Doglioni D, Rodella S, Bresaola E, Iacono C, Serio G, Iannucci A, Scarpa A. Immunodetection of proliferating cell nuclear antigen assesses growth fraction and predicts malignancy in endocrine tumors of the pancreas. Am J Surg Pathol 16:1215–1225, 1992.

    Article  PubMed  CAS  Google Scholar 

  7. Kovacs K, Asa SL. Functional endocrine pathology. Malden, MA: Blackwell Science, 1988.

    Google Scholar 

  8. Sherr CJ. G1 phase progression: cycling on cue. Cell 79:551–555, 1994.

    Article  PubMed  CAS  Google Scholar 

  9. Hunter T, Pines J. Cyclins and cancer II: cyclin D and inhibitors come of age. Cell 79:573–582, 1994.

    Article  PubMed  CAS  Google Scholar 

  10. Ponce-Castaneda MV, Lee MH, Latres E, Polyak K, Lacombe L, Montgomery K, Matthew S, Krauter K, Sheinfeld J, Massague J, Cordon-Cardo C. p27kip 1 chromosomal mapping to 12p 12-12p 13.1 and absence of mutations in human tumors. Cancer Res 55:1211–1214, 1995.

    PubMed  CAS  Google Scholar 

  11. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. Cloning of p27kip 1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66, 1994.

    Article  PubMed  CAS  Google Scholar 

  12. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 366:701–704, 1993.

    Article  PubMed  CAS  Google Scholar 

  13. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ. p57/kip2, a structurally distinct member of the p21/CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650–662, 1995.

    Article  PubMed  CAS  Google Scholar 

  14. Sherr CJ. Cancer cell cycles. Science 274:1672–1677, 1996.

    Article  PubMed  CAS  Google Scholar 

  15. Kato JY, Matsuoka M, Polyak K, Massague J, Sherr CJ. Cyclin AMP-induced G1 phase arrest mediated by an inhibitor (p27kip 1) of cyclin-dependent kinase 4 activation. Cell 79:487–496, 1994.

    Article  PubMed  CAS  Google Scholar 

  16. Dahia PL, Aguiar RC, Honegger J, Fahlbush R, Jordan S, Lowe DG, Lu X, Clayton RN, Besser GM, Grossman AB. Mutation and expression analysis of the p27kip 1 gene in corticotropin-secreting tumors. Oncogene 16:69–76, 1998.

    Article  PubMed  CAS  Google Scholar 

  17. Ikeda H, Yoshimoto T, Shida N. Molecular analysis of p21 and p27 genes in human pituitary adenomas. Br. J. Cancer 76:1119–1123, 1997.

    PubMed  CAS  Google Scholar 

  18. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K. Mice lacking p27kip 1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707–720, 1996.

    Article  PubMed  CAS  Google Scholar 

  19. Fero ML, Rande IE, Gurley KE, Roberts JM, Kemp CJ. The murine gene p27kip1 is haploinsufficient for tumour suppression. Nature 396:177–180, 1998.

    Article  PubMed  CAS  Google Scholar 

  20. Elisei R, Shiohara M, Koeffler HP, Fagin JA. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Cancer 83:2185–2193, 1998.

    Article  PubMed  CAS  Google Scholar 

  21. Zedenius J, Larsson C, Wallin G, Backdahl M, Aspenblad U, Hoog A, Borresen AL, Auer G. Alterations of p53 and expression of WAF1/p21 in human thyroid tumors. Thyroid 6:1–9, 1996.

    Article  PubMed  CAS  Google Scholar 

  22. Pagano M, Tam SW, Theodoras AM, Romero-Beer P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682–685, 1995.

    Article  PubMed  CAS  Google Scholar 

  23. Hengst L, Reed SI. Translational control of p27kip 1 accumulation during the cell cycle. Science 271:1861–1864, 1996.

    Article  PubMed  CAS  Google Scholar 

  24. Qian X, Jin L, Grande JP, Lloyd RV. Transforming growth factor-B and p27 expression in pituitary cells. Endocrinology 137:3051–3060, 1996.

    Article  PubMed  CAS  Google Scholar 

  25. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE. Cyclin E-CDK2 is a regulator of p27kip1. Genes Dev 11:1464–1478, 1997.

    Article  PubMed  CAS  Google Scholar 

  26. Pagano M, Tam SW, Theodoras AM, Romero-Beer P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclindependent kinase inhibitor p27. Science 269:682–685, 1995.

    Article  PubMed  CAS  Google Scholar 

  27. Qian X, Jin L, Kulig E, Lloyd RV. DNA methylation regulates p27kip 1 expression in rodent pituitary cell lines. Am J Pathol 153:1475–1482, 1998.

    PubMed  CAS  Google Scholar 

  28. Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B. Growth arrest by the cyclin-dependent kinase inhibitor p27kip 1 is abrogated by c-Myc. EMBO J 15:6595–6604, 1996.

    PubMed  CAS  Google Scholar 

  29. Cheng M, Sexl V, Sherr CJ, Roussel MF. Assembly of cyclin D-dependent kinase and titration of p27kip 1 regulated by mitogen-activated protein kinase (MEK1). Proc Natl Acad Sci USA 95:1091–1096, 1998.

    Article  PubMed  CAS  Google Scholar 

  30. Kaplan MH, Daniel C, Schindler U, Grusby MJ. Stat protein control lymphocyte proliferation by regulating p27kip 1 expression. Mol Cell Biol 18:1996–2003, 1998.

    PubMed  CAS  Google Scholar 

  31. Katayose Y, Kim M, Rakkar ANS, Li Z, Cowan KH, Seth P. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 57:5441–5445, 1997.

    PubMed  CAS  Google Scholar 

  32. Perez-Juste G, Aranda A. The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation. J Biol Chem 274:5026–5031, 1999.

    Article  PubMed  CAS  Google Scholar 

  33. St Croix B, Florens VA, Rak JW, Flanagan M, Bhattacharya N, Slingerland JM, Kerbel RS. Impact of the cyclin-dependent kinase inhibitor p27kip 1 on resistance of tumor cells to anticancer agents. Nat Med 2:1204–1210, 1996.

    Article  PubMed  CAS  Google Scholar 

  34. Ophascharoensuk V, Fero ML, Hughes J, Roberts JM, Shankland SJ. The cyclin-dependent kinase inhibitor p27kip 1 safeguards against inflammatory injury. Nat Med 4:575–580, 1998.

    Article  PubMed  CAS  Google Scholar 

  35. Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillett CE, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O’Hare MJ, Lu X. High level expression of p27kip 1 and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27kip 1 and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 94:6380–6385, 1997.

    Article  PubMed  CAS  Google Scholar 

  36. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM. Expression of cell-cycle regulators p27kip 1 and cyclin E, alone and in combination, correlates with survival in young breast cancer patients. Nat Med 3:222–225, 1997.

    Article  PubMed  CAS  Google Scholar 

  37. Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Marava-Protzner I, Kapuska L, Fransen E, Pritchard KI, Slingerland JM. Decreased levels of the cell-cycle inhibitor p27kip 1 protein: prognostic implications in primary breast cancer. Nat Med 3:227–230, 1997.

    Article  PubMed  CAS  Google Scholar 

  38. Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, Lavin P, Draetta G, Pagano M, Loda M. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1ab) invasive breast carcinoma. Cancer Res 57:1259–1263, 1997.

    PubMed  CAS  Google Scholar 

  39. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinoma. Nat Med 3:231–234, 1997.

    Article  PubMed  CAS  Google Scholar 

  40. Ciaparrone M, Yamamoto H, Yao Y, Sgambato A, Cattoretti G, Tomita N, Monden T, Rotterdam H, Weinstein IB. Localization and expression of p27kip 1 in multistage colorectal carcinogenesis. Cancer Res 58:114–122, 1998.

    PubMed  CAS  Google Scholar 

  41. Singh SP, Lipman J, Goldman H, Ellis FH, Aizenman L, Cangi MG, Signoretti S, Chiaur DS, Pagano M, Loda M. Loss or altered subcellular localization of p27 in Barrett’s associated adenocarcinoma. Cancer Res 58:1730–1735, 1998.

    PubMed  CAS  Google Scholar 

  42. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Susimachi K, Akiyoshi T. p27 expression and gastric carcinoma. Nat Med 3:593, 1997.

    Article  PubMed  CAS  Google Scholar 

  43. Esposito V, Baldi A, DeLuca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M, Giordano A. Prognostic role of the cyclin-dependent kinase inhibitor p27 in nonsmall cell lung cancer. Cancer Res 57:3381–3385, 1997.

    PubMed  CAS  Google Scholar 

  44. Kawana H, Tamaru J, Tanaka T, Hirai A, Saito Y, Kitagawa M, Mikata A, Harigaya K, Kuriyama T. Role of p27kip 1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. Am J Pathol 153:505–513, 1998.

    PubMed  CAS  Google Scholar 

  45. Yatabe Y, Masuda A, Koshikowa T, Nakamura S, Kuroishi T, Osada H, Takahashi T, Mitsudomi T, Takahashi T. p27kip 1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. Cancer Res 58:1042–1047, 1998.

    PubMed  CAS  Google Scholar 

  46. Tsihlias J, Kapusta LR, DeBuer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM. Loss of cyclin-dependent kinase inhibitor p27kip 1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 58:542–548, 1998.

    PubMed  CAS  Google Scholar 

  47. Yang RM, Naitoh HJ, Murphy M, Wang HJ, Phillipson J, DeKernion JB, Loda M, Reiter RE. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol 159:941–945, 1998.

    Article  PubMed  CAS  Google Scholar 

  48. Cheville JC, Lloyd RV, Sebo TJ, Cheng L, Erickson L, Bostwick DG, Lohse CM, Wollan P. Expression of p27kip 1 in prostatic adenocarcinoma. Modern Pathol 11:324–328, 1998.

    CAS  Google Scholar 

  49. Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI. Distinct altered patterns of p27kip 1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst 90:1284–1291, 1998.

    Article  PubMed  CAS  Google Scholar 

  50. Sanchez-Beato M, Saez AI, Martinez-Montero JC, Sol Mateo M, Sanchez-Verde L, Villuendas R, Troncone G, Piris MA. Cyclindependent kinase inhibitor p27kip 1 in lymphoid tissue: p27kip 1 expression is inversely proportional to the proliferative index. Am J Pathol 151:151–160, 1997.

    PubMed  CAS  Google Scholar 

  51. Quintanilla-Martinez L, Thieblemant C, Fend F, Kumar S, Pinyal M, Campo E, Jaffe ES, Raffeld M. Mantle cell lymphomas lack expression of p27kip 1, a cyclin-dependent kinase inhibitor. Am J Pathol 153:175–182, 1998.

    PubMed  CAS  Google Scholar 

  52. Lloyd RV, Jin L, Qian X, Kulig E. Aberrant p27kip 1 expression in endocrine and other tumors. Am J Pathol 150:401–407, 1997.

    PubMed  CAS  Google Scholar 

  53. Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV. Expression of p27kip 1 and Ki-67 in benign and malignant thyroid tumors. Modern Pathol 11:169–174, 1998.

    CAS  Google Scholar 

  54. Resnick MB, Schacter P, Finkelstein Y, Kellner Y, Cohen O. Immunohistochemical analysis of p27/kip 1 expression in thyroid carcinoma. Modern Pathol 11:735–739, 1998.

    CAS  Google Scholar 

  55. Wang S, Wuu J, Savas L, Patwardhan N, Khan A. The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. Hum Pathol 29:1304–1309, 1998.

    Article  PubMed  CAS  Google Scholar 

  56. Lloyd RV, Ferrero JA, Jin L, Sebo T. TGF-B, TGF-B receptors: Ki-67 and p27kip1 expression in papillary thyroid carcinomas. Endocr Pathol 4:293–300, 1997.

    Google Scholar 

  57. Tallini G, Garcia-Rostan G, Herrero A, Zelterman D, Viale G, Bosari S, Carcangiu ML. Downregulation of p27KIPI and KI67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol 23:678–685, 1999.

    Article  PubMed  CAS  Google Scholar 

  58. Okayasu I, Osakabe T, Onozawa M, Mikami T, Fujiwara M. p53 and p21 (WAF1) expression in lymphocytic thyroiditis and thyroid tumors. Clin Immunol Immunopathol 88:183–191, 1998.

    Article  PubMed  CAS  Google Scholar 

  59. Shi Y, Zou M, Farid NR, al-Sedairy ST. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas. Br J Cancer 74:1336–1341, 1996.

    PubMed  CAS  Google Scholar 

  60. Zou M, Shi Y, Farid NR, Al-Sedairy ST. Inverse association between cyclin D1 overexpression and retinoblastoma gene mutation in thyroid carcinomas. Endocrine 8:61–64, 1998.

    Article  PubMed  CAS  Google Scholar 

  61. Lazzereschi D, Sambuco L, Scalzo CC, Ranieri AR, Mincione G, Nardi F, Colletta G. Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinomas. Int J Cancer 76:806–811, 1998.

    Article  PubMed  CAS  Google Scholar 

  62. Erickson LA, Jin L, Goellner JR, Lohse C, Pankratz VS, Zukerberg LR, Thompson GB, van Heerden JA, Grant CS, Lloyd RV. Pathologic features, proliferative activity and cyclin D1 expression in Hurthle cell neoplasms of the thyroid. Modern Pathol, 13:186–192, 2000.

    Article  CAS  Google Scholar 

  63. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A. A novel cyclin encoded by a bcl-linked candidate oncogene. Nature 350:512–515, 1991.

    Article  PubMed  CAS  Google Scholar 

  64. Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K, Meeker TC. Characterization of a candidate bcl-1 gene. Mol Cell Biol 11:4846–4853, 1991.

    PubMed  CAS  Google Scholar 

  65. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127–2133, 1993.

    PubMed  CAS  Google Scholar 

  66. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein IB. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52:2980–2983, 1992.

    PubMed  CAS  Google Scholar 

  67. Horenstein MG, Cesarman E, Wang X, Linkov I, Prieto VG, Louie CD. Cyclin D1 and retinoblastoma protein expression in Kaposi’s sarcoma. J Cutan Pathol 24:585–589, 1997.

    Article  PubMed  CAS  Google Scholar 

  68. Sutter T, Doi S, Carnevale KA, Arber N, Weinstein IB. Expression of cyclins D1 and E in human colon adenocarcinomas. J Med 28:285–309, 1997.

    PubMed  CAS  Google Scholar 

  69. Han EK, Lim JT, Arber N, Rubin MA, Xing WQ, Weinstein IB. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate 35:95–101, 1998.

    Article  PubMed  CAS  Google Scholar 

  70. Proctor AJ, Coombs LM, Cairns JP, Knowles MA. Amplification at chromosome 11q13 in transitional cell tumors of the bladder. Oncogene 6:789–795, 1991.

    PubMed  CAS  Google Scholar 

  71. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55:975–978, 1995.

    PubMed  CAS  Google Scholar 

  72. Muro-Cacho CA, Munoz-Antonia T, Livingston S, Klotch D. Transforming growth factor beta receptors and p27kip1 in thyroid carcinoma. Arch Otolaryngol Head Neck Surg 125:76–81, 1999.

    PubMed  CAS  Google Scholar 

  73. Muro-Cacho CA, Holt T, Klotch D, Mora L, Livingston S, Futran N. Cyclin D1 expression as a prognostic parameter in papillary carcinoma of the thyroid. Otolaryngol Head Neck Surg 120:200–207, 1999.

    Article  PubMed  CAS  Google Scholar 

  74. Jin L, Qian X, Kulig E, Sanno N, Scheithauer BW, Kovacs K, Young WF Jr, Lloyd RV. Transforming growth factor-B, transforming growth factor-B receptor II, and p27kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 151:509–519, 1997.

    PubMed  CAS  Google Scholar 

  75. Zhao D, Tomono Y, Nose T. Expression of p27kip1 and Ki-67 in pituitary adenomas: an investigation of marker of adenoma invasiveness. Acta Neurochir (Wien) 141:187–192, 1999.

    Article  CAS  Google Scholar 

  76. Takeuchi S, Koeffler HP, Hinton DR, Miyoshi I, Melmed S, Shimon I. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors. J Endocrinol 157:337–341, 1998.

    Article  PubMed  CAS  Google Scholar 

  77. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L, Xiong Y. CDK inhibitors p18INK4c and p27kip1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 12:2899–2911, 1998.

    PubMed  CAS  Google Scholar 

  78. Woloschak M, Yu A, Xiao J, Post KD. Frequent loss of the p16INK4a gene product in human pituitary tumors. Cancer Res 56:2493–2496, 1996.

    PubMed  CAS  Google Scholar 

  79. Woloschak M, Yu A, Post KD. Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation. Mol Carcinog 19:221–224, 1997.

    Article  PubMed  CAS  Google Scholar 

  80. Castleman B, Roth SI. Tumors of the parathyroid glands. Atlas of tumor pathology, 2nd series, fascicle 14. Washington, DC: Armed Forces Institute of Pathology, 1978.

    Google Scholar 

  81. DeLellis RA. Tumors of the parathyroid glands. Atlas of tumor pathology, 3rd series, fascicle 6. Washington, DC: Armed Forces Institute of Pathology, 1993.

    Google Scholar 

  82. Erickson LA, Jin L, Wollan P, Thompson GB, van Heerden JA, Lloyd RV. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. Am J Surg Pathol 23:288–295, 1999.

    Article  PubMed  CAS  Google Scholar 

  83. Hsi ED, Zukerberg LR, Yang W-I, Arnold A. Cyclin D1/PRAD1 expression in parathyroid adenomas. J Clin Endocrinol Metab 81:1736–1739, 1996.

    Article  PubMed  CAS  Google Scholar 

  84. Friedman E, Bale AE, Marx SJ, Norton JA, Arnold A, Tu T, Aurbach GD, Spiegel AM. Genetic abnormalities in sporadic parathyroid adenomas. J Clin Endocrinol Metab 71:293–297, 1990.

    Article  PubMed  CAS  Google Scholar 

  85. Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 318:658–662, 1988.

    Article  PubMed  CAS  Google Scholar 

  86. Arnold A, Kim HG, Gaz RD, Eddy RL, Fukushima Y, Byers MG, Shows TB, Kronenberg HM. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 83:2034–2040, 1989.

    Article  PubMed  CAS  Google Scholar 

  87. Nakazumi H, Sasano H, Iino K, Ohashi Y, Orikasa S. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms. Modern Pathol 11:1165–1170, 1998.

    CAS  Google Scholar 

  88. Iida S, Fujii H, Moriwaki K. A somatic mutation of the p21(Waf1/Cip1) gene in a human adrenocortical adenoma. Anticancer Res 17:633–636, 1997.

    PubMed  CAS  Google Scholar 

  89. Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC, Silverman A, Harper JW, Depinho RA, Elledge SJ. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151–158, 1997.

    Article  PubMed  CAS  Google Scholar 

  90. Liu J, Kahri AI, Heikkila P, Voutilainen R. Ribonucleic acid expression of the clustered imprinted genes, p57KIP2, insulin-like growth factor II, and H19, in adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab 82:1766–1771, 1997.

    Article  PubMed  CAS  Google Scholar 

  91. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, Scheithauer BW. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154:313–323, 1999.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory, Medicine and Pathology, Mayo Clinic, Rochester, MN

    L. A. Erickson MD

Authors
  1. L. A. Erickson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. A. Erickson MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erickson, L.A. p27kip 1 and other cell-cycle protein expression in normal and neoplastic endocrine tissues. Endocr Pathol 11, 109–122 (2000). https://doi.org/10.1385/EP:11:2:109

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/EP:11:2:109

Key Words

Search

Navigation